X
XMReality AB (publ)
OTC:XMMRF
XMReality AB (publ)
OTC:XMMRF
Price:
0.0091
USD
Market Closed
Market Cap:
$3.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
XMReality AB (publ)
OTC:XMMRF
|
SE |
|
Pieris Pharmaceuticals Inc
NASDAQ:PIRS
|
US |
|
Kemper Corp
NYSE:KMPR
|
US |
|
Baticim Bati Anadolu Cimento Sanayii AS
IST:BTCIM.E
|
TR |
|
T
|
Tus Pharmaceutical Group Co Ltd
SZSE:000590
|
CN |
|
Mazda Ltd
NSE:MAZDA
|
IN |
|
A
|
AlphaVest Acquisition Corp
NASDAQ:ATMV
|
US |
|
E
|
Emerson Electric Co
BMV:EMR
|
US |
Balance Sheet
Balance Sheet Decomposition
XMReality AB (publ)
XMReality AB (publ)
Balance Sheet Decomposition is not available for
XMReality AB (publ)
XMReality AB (publ)
Balance Sheet
XMReality AB (publ)
XMReality AB (publ)
Currency: SEK
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Cash & Cash Equivalents |
0
|
2
|
1
|
22
|
46
|
38
|
9
|
19
|
45
|
8
|
2
|
0
|
0
|
|
| Cash |
0
|
2
|
1
|
22
|
46
|
38
|
9
|
19
|
45
|
8
|
2
|
0
|
0
|
|
| Total Receivables |
0
|
1
|
1
|
2
|
5
|
4
|
6
|
8
|
7
|
27
|
4
|
8
|
3
|
|
| Accounts Receivables |
0
|
0
|
1
|
2
|
5
|
4
|
5
|
7
|
6
|
7
|
3
|
7
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
20
|
0
|
1
|
0
|
|
| Inventory |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
0
|
|
| Total Current Assets |
1
|
3
|
4
|
25
|
53
|
44
|
16
|
28
|
54
|
37
|
7
|
9
|
4
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
2
|
5
|
7
|
12
|
15
|
16
|
13
|
10
|
16
|
20
|
20
|
17
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
6
+164%
|
9
+61%
|
33
+262%
|
67
+105%
|
59
-11%
|
33
-45%
|
42
+27%
|
64
+54%
|
53
-17%
|
27
-48%
|
29
+6%
|
21
-28%
|
|
| Liabilities | ||||||||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
3
|
3
|
2
|
2
|
2
|
3
|
2
|
4
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
2
|
3
|
6
|
9
|
14
|
16
|
18
|
14
|
3
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
2
|
2
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
14
|
12
|
|
| Total Current Liabilities |
1
|
1
|
2
|
4
|
8
|
11
|
12
|
17
|
19
|
22
|
19
|
24
|
12
|
|
| Long-Term Debt |
0
|
0
|
4
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
|
| Total Liabilities |
1
N/A
|
2
+108%
|
6
+300%
|
6
-5%
|
10
+66%
|
12
+18%
|
13
+7%
|
17
+34%
|
19
+12%
|
22
+17%
|
21
-5%
|
24
+15%
|
12
-50%
|
|
| Equity | ||||||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
2
|
3
|
5
|
6
|
0
|
|
| Retained Earnings |
2
|
8
|
12
|
25
|
61
|
95
|
124
|
153
|
187
|
233
|
249
|
276
|
0
|
|
| Additional Paid In Capital |
4
|
12
|
15
|
48
|
108
|
129
|
129
|
164
|
230
|
262
|
250
|
275
|
0
|
|
| Other Equity |
0
|
0
|
0
|
3
|
10
|
12
|
14
|
12
|
0
|
0
|
7
|
5
|
9
|
|
| Total Equity |
1
N/A
|
4
+194%
|
3
-32%
|
27
+866%
|
57
+114%
|
48
-16%
|
20
-57%
|
25
+23%
|
45
+82%
|
31
-31%
|
7
-78%
|
5
-23%
|
9
+75%
|
|
| Total Liabilities & Equity |
2
N/A
|
6
+164%
|
9
+61%
|
33
+262%
|
67
+105%
|
59
-11%
|
33
-45%
|
42
+27%
|
64
+54%
|
53
-17%
|
27
-48%
|
29
+6%
|
21
-28%
|
|
| Shares Outstanding | ||||||||||||||
| Common Shares Outstanding |
15
|
15
|
17
|
20
|
20
|
23
|
23
|
40
|
72
|
78
|
158
|
619
|
1 186
|
|
Switch to:
Switch to:
See Also
Discover More
